Lifestyle Intervention, Heart Failure and Myocardial Infarction in T2D

Click here to subscribe to Diabetesincontrol.com

Categories: Health | Welfare Health Education Age: 14 until 18 year 19 until 30 year 31 until 64 years

3 years ago

Html
Text

Plus: benefits of Vitamin D, green tea, coffee

Saturday, Dec. 19, 2020 : Issue #1090

TOP STORIES - Diabetes News & Research

Effect of Lifestyle Intervention on Heart Failure and Myocardial Infarction in T2D
Green Tea and Coffee Benefits for Diabetes
Could Vitamin D Have a Role in T2DM?

Letter from the Editor
The first batch of COVID-19 vaccines has made its way into places across the US. This first wave will be the easiest to give as we focus on healthcare workers and other first line responders. As more doses become available, we will have more decisions to make. Should the injections go to nursing home residents, or should they go to patients with diabetes who have an increased risk of death if they contract the coronavirus? Although the news networks make it seem like this will solve all our problems, it appears that it will be mid-summer before at least 50% of the US population is inoculated.
We are still going to have to keep up our safety precautions, disinfecting, mask wearing and the like. My fear is that we will relax our vigilance, and people who would be protected easily will let down their guard. Please don’t let your patients stop wearing masks or social distancing, or this pandemic will last much longer than we would ever want it to.
Thank you for your continued care for your patients and have a safe holiday season.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief

Did You Know? Diabetes is a Global Pandemic:

COVID-19 deaths are predicted to be possibly ½ million by February 1; worldwide, in the 20–99 years age range, approximately 5 million deaths/year are attributable to diabetes.
T2D can no longer be considered, as it once was, a disease of affluence or developed nations, with more than 60% of all individuals with the disorder residing outside the developed countries. China and India are the two major epicenters of the diabetes epidemic. Still, sub-Saharan Africa, Oceania, and Latin America also have extensive (and rapidly increasing) numbers of people with diabetes. The increase in the prevalence of diabetes is intimately linked to economic development and the subsequent changes in lifestyle that promote an obesogenic environment. Although the link between Obesity and T2D is linear, certain ethnic groups (such as Asian Indians) develop T2D at relatively low BMI levels. Defects in beta-cell function, mediated by genetic or early-life influences, may underlie many of these cases of "lean" T2D. A thorough understanding of the etiopathogenesis of diabetes in various ethnic groups is essential to plan the most cost-effective therapeutic and preventive strategies. It is unlikely that "one size" would fit all. When translating the results of international trials to middle- and low-income countries, low-cost, culturally adaptable solutions will have to be used along with community empowerment if the increasing diabetes epidemic is to be halted in its tracks, or at least slowed down. The time to act is now!
Diabetes 2017 Jun; 66(6): 1432-1442

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Abdullah Al-Ajmi, PharmD Candidate, Skaggs School of Pharmacy and Pharmaceutical Sciences

Shana Indawala, PharmD Candidate, University of South Florida Health, Taneja College of Pharmacy

Leyany Feijoo Ramos, PharmD. Candidate, LECOM School of Pharmacy

Melinda Rodriguez, PharmD Candidate 2021, Lake Erie College of Osteopathic Medicine – L|E|C|O|M School of Pharmacy

A'Kira Shavers, PharmD Candidate, South College School of Pharmacy

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com

©2020 HIPER, LLC. All rights reserved.
This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States
DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe

Lifestyle Intervention, Heart Failure and Myocardial Infarction in T2D

Saturday, Dec. 19, 2020 : Issue #1090

TOP STORIES - Diabetes News & Research

TOP STORIES - Diabetes News and Research

Did You Know? Diabetes is a Global Pandemic:

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Share on

Other newsletters from Diabetesincontrol.com

Related newsletters

View other categories